Resistance exercise to attenuate lean mass loss during tirzepatide therapy for obesity

Lift weights when on GLPs

Nov 10, 2026, 7:27 PM UTC · 12 posts · Original thread on X

12 posts · 4 embedded images · 0 video posters (videos open on X) · standalone / offline
#1 Nov 10, 2026, 7:27 PM UTC
This new tirzepatide study is eye-opening.

120 adults took the drug for 40 weeks, and half of them also lifted weights 3x a week. Both groups lost about 50 lbs.

But when they tested strength, the two groups looked nothing alike.

Here's the breakdown: (1/11)
#2 Nov 10, 2026, 7:27 PM UTC
First, some context: this is the first randomized trial to test resistance training in combination with tirzepatide.

Everyone was 50 to 70, overweight or obese, and sedentary at the start.

- Half of them kept their usual activities
- Half trained 3x a week
#3 Nov 10, 2026, 7:27 PM UTC
Unless you've been living under a rock, you know that GLP-1s cause substantial weight and fat loss, but they also decrease lean tissue, possibly impairing muscle function.

Muscle-preserving drugs are already being tested for this such as apitegromab, bimagrumab, etc. but...
#4 Nov 10, 2026, 7:27 PM UTC
The study's point is that those approaches overlook something safe and readily available: lifting.

(not surprised, but let's look at the results)
#5 Nov 10, 2026, 7:27 PM UTC
Body weight decreased similarly in both groups (22.6 kg vs. 22.3 kg), and so did total fat mass.

The DXA scans, taken every 8 weeks, show dramatic changes from obese to non-obese bodies:
#6 Nov 10, 2026, 7:27 PM UTC
Lean tissue went down in both groups, but to a lesser extent in the lifters.

Lifting didn't fully prevent it, but it cut the loss from 4.7 kg to 3.6 kg.

In the paper's words, the muscle lost over 40 weeks "approximates changes that might occur over a decade or more of aging."
#7 Nov 10, 2026, 7:27 PM UTC
Strength is where the two groups split.

In the drug-only group, bench press, lat pulldown and knee extension all decreased, by 8.4%, 6.5% and 9.0%.

In the lifting group, the same lifts increased by 10.7%, 15.7% and 17.5%.
#8 Nov 10, 2026, 7:27 PM UTC
That was the part that really stuck with me.

Only a minority of people in either group reported lethargy or weakness (about 15-17%).

So feeling fine told them nothing about their actual strength. And after age 50, strength already declines about 12-15% per decade.
#9 Nov 10, 2026, 7:27 PM UTC
Their training program was nothing fancy.

Each 1-hour session alternated between upper and lower body, with the weight going up over time.

Squats, deadlifts, leg press, lat pulldowns, shoulder press, chest press.

People showed up to 91% of sessions.
#10 Nov 10, 2026, 7:27 PM UTC
I'm on GLP-1s, and strength training has always been a crucial part of my protocol to remain strong and lean.

The problem is, most people start a GLP-1 without nutrition advice or weight training.
#11 Nov 10, 2026, 7:27 PM UTC
Then they act surprised when the dose goes up, their appetite is crushed, and their muscle disappears.

GLP-1s are revolutionary, but they're still drugs, and they work best as part of the whole picture: food, lifting, and sleep.
#12 Nov 10, 2026, 7:27 PM UTC
I'll leave the full study here if you want to check it out yourself:

nature.com/articles/s4159…

Not medical advice.
Resistance exercise to attenuate lean mass loss during tirzepatide therapy for obesity: a randomized controlled trial
Nature Medicine - Participants undergoing resistance exercise while receiving tirzepatide lost less lean mass than participants receiving tirzepatide alone.
nature.com/articles/s4159…